558 related articles for article (PubMed ID: 31523787)
1. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ
Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787
[TBL] [Abstract][Full Text] [Related]
2. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
Ezzat M; El-Gammasy T; Shaheen K; Shokr E
Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
[TBL] [Abstract][Full Text] [Related]
3. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.
Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453
[TBL] [Abstract][Full Text] [Related]
4. The correlational research among serum CXCL13 levels, circulating plasmablasts and memory B cells in patients with systemic lupus erythematosus: A STROBE-compliant article.
Fang C; Luo T; Lin L
Medicine (Baltimore); 2017 Dec; 96(48):e8675. PubMed ID: 29310341
[TBL] [Abstract][Full Text] [Related]
5. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE).
Schiffer L; Kümpers P; Davalos-Misslitz AM; Haubitz M; Haller H; Anders HJ; Witte T; Schiffer M
Nephrol Dial Transplant; 2009 Dec; 24(12):3708-12. PubMed ID: 19602475
[TBL] [Abstract][Full Text] [Related]
6. The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity.
Zeng Y; Zhang Y; Lin Y; Wang X; Chen Q; Huang Q; Wang J; Jiang L; Xiao Y
Clin Exp Med; 2021 Nov; 21(4):611-619. PubMed ID: 33844093
[TBL] [Abstract][Full Text] [Related]
7. CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.
Niederkorn A; Frühauf J; Schwantzer G; Wutte N; Painsi C; Werner S; Stradner M; Berghold A; Hermann J; Aberer E
Arch Dermatol Res; 2018 Aug; 310(6):485-493. PubMed ID: 29728857
[TBL] [Abstract][Full Text] [Related]
8. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
9. Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: A systematic review and meta-analysis.
Guan SY; Cai HY; Wang P; Lv TT; Liu LN; Mao YM; Zhao CN; Wu Q; Dan YL; Sam NB; Wang DG; Pan HF
Int J Rheum Dis; 2019 Oct; 22(10):1803-1813. PubMed ID: 31468723
[TBL] [Abstract][Full Text] [Related]
10. Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.
Huang Q; Tao SS; Zhang YJ; Zhang C; Li LJ; Zhao W; Zhao MQ; Li P; Pan HF; Mao C; Ye DQ
Clin Rheumatol; 2015 Oct; 34(10):1713-20. PubMed ID: 25935455
[TBL] [Abstract][Full Text] [Related]
11. B-cell-attracting chemokine-1 (BCA-1/CXCL13) in systemic lupus erythematosus, its correlation to disease activity and renal involvement.
Hafez SS; Saad Wel S; Shedid NH
Egypt J Immunol; 2014; 21(2):23-32. PubMed ID: 25812350
[TBL] [Abstract][Full Text] [Related]
12. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.
Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM
Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723
[TBL] [Abstract][Full Text] [Related]
13. Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis : A meta-analysis.
Bae SC; Lee YH
Z Rheumatol; 2020 Apr; 79(3):312-318. PubMed ID: 31428858
[TBL] [Abstract][Full Text] [Related]
14. Association of CXCL13 serum level and ultrasonographic findings of joints in patients with systemic lupus erythematosus and Jaccoud's arthropathy.
Ribeiro DS; Lins CF; Galvão V; Santos WGD; Rosa G; Machicado V; Pedreira AL; da Fonseca EP; Souza APMD; Baleeiro C; Ferreira LG; Oliveira IS; Gama da Silva JPC; Atta AM; Santiago MB
Lupus; 2018 May; 27(6):939-946. PubMed ID: 29338586
[TBL] [Abstract][Full Text] [Related]
15. Circulating Matrix Metalloproteinase-9 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis.
Mao YM; Wang S; Zhao CN; Wu Q; Dan YL; Guan SY; Lv TT; Liu LN; Wang P; Pan HF
Curr Pharm Des; 2018; 24(16):1780-1787. PubMed ID: 29879882
[TBL] [Abstract][Full Text] [Related]
16. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
[TBL] [Abstract][Full Text] [Related]
17. Circulating prolactin level in systemic lupus erythematosus and its correlation with disease activity: a meta-analysis.
Song GG; Lee YH
Lupus; 2017 Oct; 26(12):1260-1268. PubMed ID: 28420051
[TBL] [Abstract][Full Text] [Related]
18. CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis - from bench to bedside?
Schiffer L; Worthmann K; Haller H; Schiffer M
Clin Exp Immunol; 2015 Jan; 179(1):85-9. PubMed ID: 25138065
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
Sellam J; Proulle V; Jüngel A; Ittah M; Miceli Richard C; Gottenberg JE; Toti F; Benessiano J; Gay S; Freyssinet JM; Mariette X
Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990
[TBL] [Abstract][Full Text] [Related]
20. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis.
Wang B; Shao X; Wang D; Xu D; Zhang JA
Autoimmun Rev; 2017 Jul; 16(7):756-765. PubMed ID: 28483543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
